Published in ChemMedChem on June 01, 2007
Large-scale prediction and testing of drug activity on side-effect targets. Nature (2012) 3.88
Protein promiscuity and its implications for biotechnology. Nat Biotechnol (2009) 2.78
Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol (2015) 2.18
Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov (2011) 2.12
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat Rev Drug Discov (2012) 1.47
A survey of across-target bioactivity results of small molecules in PubChem. Bioinformatics (2009) 1.39
The influence of the 'organizational factor' on compound quality in drug discovery. Nat Rev Drug Discov (2011) 1.32
The chemical basis of pharmacology. Biochemistry (2010) 1.30
ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res (2014) 1.05
Target fishing for chemical compounds using target-ligand activity data and ranking based methods. J Chem Inf Model (2009) 1.02
Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol (2009) 1.01
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Front Pharmacol (2014) 1.00
Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key. PLoS One (2013) 0.94
Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach. J Chem Inf Model (2015) 0.86
In silico methods for drug repurposing and pharmacology. Wiley Interdiscip Rev Syst Biol Med (2016) 0.85
A theoretical entropy score as a single value to express inhibitor selectivity. BMC Bioinformatics (2011) 0.85
A chemogenomic analysis of ionization constants--implications for drug discovery. ChemMedChem (2013) 0.81
Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity? BMC Pharmacol (2010) 0.79
Systematic analysis of gene properties influencing organ system phenotypes in mammalian perturbations. Bioinformatics (2014) 0.79
eMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein models. PLoS Comput Biol (2014) 0.77
Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network. Evid Based Complement Alternat Med (2013) 0.76
The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing. PLoS One (2017) 0.75
Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning. Methods Mol Biol (2017) 0.75
Large-scale prediction and testing of drug activity on side-effect targets. Nature (2012) 3.88
Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol (2007) 3.17
Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. ChemMedChem (2007) 2.36
Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol (2009) 2.21
Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov (2009) 1.95
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model (2006) 1.95
Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Org Biomol Chem (2004) 1.79
Mapping adverse drug reactions in chemical space. J Med Chem (2009) 1.77
Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov (2010) 1.73
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett (2013) 1.72
How similar are similarity searching methods? A principal component analysis of molecular descriptor space. J Chem Inf Model (2009) 1.69
Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics. J Chem Inf Model (2008) 1.69
Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information. J Comput Aided Mol Des (2011) 1.68
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther (2003) 1.62
A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother (2009) 1.59
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry (2006) 1.57
A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal Biochem (2007) 1.56
Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov Today (2005) 1.55
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem (2006) 1.54
Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet (2004) 1.53
Enrichment of high-throughput screening data with increasing levels of noise using support vector machines, recursive partitioning, and laplacian-modified naive bayesian classifiers. J Chem Inf Model (2006) 1.52
Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet (2008) 1.48
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat Rev Drug Discov (2012) 1.47
Anti-MRSA agent discovery using diversity-oriented synthesis. Angew Chem Int Ed Engl (2008) 1.47
Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model (2009) 1.40
Diversity-oriented synthesis; a spectrum of approaches and results. Org Biomol Chem (2008) 1.37
Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures. J Chem Inf Comput Sci (2004) 1.35
From in silico target prediction to multi-target drug design: current databases, methods and applications. J Proteomics (2011) 1.35
Understanding and classifying metabolite space and metabolite-likeness. PLoS One (2011) 1.29
Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model (2012) 1.29
Recognizing pitfalls in virtual screening: a critical review. J Chem Inf Model (2012) 1.27
Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. IDrugs (2006) 1.25
New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching. J Chem Inf Model (2006) 1.24
Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. J Med Chem (2006) 1.23
Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci (2003) 1.23
Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem Biol (2012) 1.21
An ontology for pharmaceutical ligands and its application for in silico screening and library design. J Chem Inf Comput Sci (2002) 1.20
A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci U S A (2002) 1.13
Skeletal diversity construction via a branching synthetic strategy. Chem Commun (Camb) (2006) 1.12
In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window. J Chem Inf Model (2013) 1.12
A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization. BMC Bioinformatics (2010) 1.11
PAMPA--critical factors for better predictions of absorption. J Pharm Sci (2007) 1.10
Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint. Comb Chem High Throughput Screen (2007) 1.09
Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke (2010) 1.07
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res (2007) 1.07
Retracted Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem (2003) 1.07
Rehabilitation outcome of anoxic-ischaemic encephalopathy survivors with prolonged disorders of consciousness. Resuscitation (2013) 1.06
Molecular lipophilicity in protein modeling and drug design. Curr Med Chem (2007) 1.04
Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today (2013) 1.04
Random forest Gini importance favours SNPs with large minor allele frequency: impact, sources and recommendations. Brief Bioinform (2011) 1.03
On scaffolds and hopping in medicinal chemistry. Mini Rev Med Chem (2006) 1.02
Characterization of activity landscapes using 2D and 3D similarity methods: consensus activity cliffs. J Chem Inf Model (2009) 1.02
Library design for fragment based screening. Curr Top Med Chem (2005) 1.02
Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data. PLoS Comput Biol (2013) 1.01
ICL670A: preclinical profile. Adv Exp Med Biol (2002) 1.01
Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol (2011) 1.01
Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorg Med Chem Lett (2005) 1.00
Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells. J Biol Chem (2013) 1.00
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol (2005) 0.99
Clustering and rule-based classifications of chemical structures evaluated in the biological activity space. J Chem Inf Model (2007) 0.99
Relationships between Molecular Complexity, Biological Activity, and Structural Diversity. J Chem Inf Model (2006) 0.99
Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci (2003) 0.98
Fishing the target of antitubercular compounds: in silico target deconvolution model development and validation. J Proteome Res (2009) 0.98
Evaluation of the utility of homology models in high throughput docking. J Mol Model (2007) 0.98
Nutritional screening for risk prediction in patients scheduled for extra-abdominal surgery. Nutrition (2013) 0.98
P-glycoprotein substrate models using support vector machines based on a comprehensive data set. J Chem Inf Model (2011) 0.97
How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. J Chem Inf Model (2013) 0.97
Bilateral loss of cortical SSEP responses is compatible with good outcome after cardiac arrest. J Neurol (2012) 0.97
Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data. J Chem Inf Model (2007) 0.96
General melting point prediction based on a diverse compound data set and artificial neural networks. J Chem Inf Model (2005) 0.96
Matched molecular pair analysis: significance and the impact of experimental uncertainty. J Med Chem (2014) 0.95
Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Mov Disord (2010) 0.95
Diversity-oriented synthesis of macrocyclic peptidomimetics. Proc Natl Acad Sci U S A (2011) 0.94
The accuracy of EGSnrc, Geant4 and PENELOPE Monte Carlo systems for the simulation of electron scatter in external beam radiotherapy. Phys Med Biol (2009) 0.94
Chemogenomics approaches to rationalizing the mode-of-action of traditional Chinese and Ayurvedic medicines. J Chem Inf Model (2013) 0.93
Alpha shapes applied to molecular shape characterization exhibit novel properties compared to established shape descriptors. J Chem Inf Model (2009) 0.93
IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology. Assay Drug Dev Technol (2011) 0.93